Chilean authorities announced that they have detected the H1N1 flu virus in turkeys, marking the first time the virus has been found outside of humans and pigs.
In a new set of guidelines, the WHO stated otherwise healthy people infected with H1N1 do not need antivirals like Tamiflu. This decision should increase availability of the drugs to those who may need them most, as the Northern Hemisphere prepares for a second wave of H1N1 infections.
As SINOVAC Biotech Company reported a successful preliminary clinical trial for its A/H1N1 influenza vaccine, the WHO urged China to share its vaccine with needy countries.
While many countries hurried to make mass vaccination plans (particularly in the Northern Hemisphere), New Zealand has taken a "wait and see" approach.
In the US, the President's Council of Advisors on Science and Technology urged the government to help drug companies expedite the supply of swine flu drugs and vaccines. They also warned that 30,00 to 90,000 Americans could die, almost 2 million be hospitalized, and 30% to 50% of the country could be infected.
French researchers reported that H1N1 was 100 times more likely to directly cause death than seasonal influenza in a study performed in Mauritius and New Caledonia.
In an effort to avoid a rapid increase in cases, the Sultanate of Oman is waiting until December to resume classes.
HealthMap brings together disparate data sources to achieve a unified and comprehensive view of the current global state of infectious diseases and their effect on human and animal health. This freely available Web site integrates outbreak data of varying reliability, ranging from news sources (such as Google News) to curated personal accounts (such as ProMED) to validated official alerts (such as World Health Organization). Through an automated text processing system, the data is aggregated by disease and displayed by location for user-friendly access to the original alert. HealthMap provides a jumping-off point for real-time information on emerging infectious diseases and has particular interest for public health officials and international travelers.
No comments:
Post a Comment